Compass Wealth Management LLC Sells 6,415 Shares of Procter & Gamble Company (The) $PG

Compass Wealth Management LLC trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 67.2% during the 3rd quarter, Holdings Channel reports. The fund owned 3,125 shares of the company’s stock after selling 6,415 shares during the period. Compass Wealth Management LLC’s holdings in Procter & Gamble were worth $480,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Norges Bank purchased a new position in Procter & Gamble during the second quarter valued at approximately $5,099,644,000. Laurel Wealth Advisors LLC boosted its position in Procter & Gamble by 15,971.7% during the 2nd quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock valued at $1,117,270,000 after acquiring an additional 6,969,110 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Procter & Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after acquiring an additional 3,189,111 shares during the period. Invesco Ltd. raised its position in shares of Procter & Gamble by 21.4% in the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after acquiring an additional 2,880,895 shares in the last quarter. Finally, Lazard Asset Management LLC lifted its stake in shares of Procter & Gamble by 66.3% during the 2nd quarter. Lazard Asset Management LLC now owns 5,504,749 shares of the company’s stock worth $877,014,000 after purchasing an additional 2,195,560 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. TD Cowen reiterated a “buy” rating on shares of Procter & Gamble in a research note on Thursday, January 8th. BNP Paribas Exane cut their price objective on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a research report on Friday, January 16th. Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Morgan Stanley set a $175.00 price target on shares of Procter & Gamble in a report on Monday, October 27th. Finally, Wells Fargo & Company increased their price objective on Procter & Gamble from $158.00 to $165.00 and gave the company an “overweight” rating in a report on Friday. Fourteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $166.70.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: JPMorgan raised PG to Overweight, signaling institutional confidence that could support the stock if momentum continues. Procter & Gamble (NYSE:PG) Raised to Overweight at JPMorgan Chase & Co.
• Positive Sentiment: Another outlet reported a higher price target ($157), adding to the tape of modestly more bullish price expectations. Procter & Gamble (NYSE:PG) Price Target Raised to $157.00
• Positive Sentiment: Coverage highlighting P&G’s successful, contrarian growth moves in China’s baby-care market supports the revenue-recovery narrative and longer-term organic growth potential. Fewer Babies, Higher Sales: P&G’s Contrarian Bet in China Is Working
• Positive Sentiment: MarketBeat and other bullish write-ups argue PG has “confirmed a bottom,” citing stable dividends, share buybacks and institutional accumulation — a constructive narrative for long-term dividend/total-return investors. Procter & Gamble Confirms a Bottom—Time to Start Compounding?
• Neutral Sentiment: Goldman Sachs maintained a Hold rating with a $159 target, reflecting solid fundamentals but limited near-term upside — keeps professional sentiment mixed. Procter & Gamble: Solid Fundamentals but Limited Near-Term Upside Support a Hold Rating
• Neutral Sentiment: Zacks and other retail-focused pieces note increased investor attention and commentary from commentators (e.g., Jim Cramer), which can raise short-term volume but not necessarily change fundamentals. Procter & Gamble Company (The) (PG) is Attracting Investor Attention
• Negative Sentiment: A senior insider, Marc S. Pritchard, sold 95,903 shares (~$14.5M at ~$151.15), cutting his stake significantly — large insider sales can weigh on sentiment even if not tied to firm prospects. SEC filing: Insider Form 4 — Marc S. Pritchard

Procter & Gamble Trading Down 0.3%

NYSE PG opened at $149.64 on Tuesday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The company has a fifty day simple moving average of $144.80 and a two-hundred day simple moving average of $150.43. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.48. The stock has a market cap of $349.67 billion, a P/E ratio of 22.17, a P/E/G ratio of 5.08 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a return on equity of 32.10% and a net margin of 19.30%.The firm’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 62.67%.

Insider Buying and Selling

In other news, CAO Matthew W. Janzaruk sold 725 shares of the company’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the sale, the chief accounting officer directly owned 979 shares of the company’s stock, valued at $146,429.03. This represents a 42.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares in the company, valued at $27,601,048.05. The trade was a 34.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 96,629 shares of company stock worth $14,604,323. 0.20% of the stock is owned by insiders.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.